Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Active, Not Recruiting

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

NCT02972840

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Downey, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site New Haven, Connecticut, United States
View all 228 locations
View Trial Details
Active, Not Recruiting

A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma

NCT05951959

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Hackensack, New Jersey, United States
  • Research Site Stony Brook, New York, United States
  • Research Site Cleveland, Ohio, United States
  • Research Site Philadelphia, Pennsylvania, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma

NCT02159755

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • NYP/Weill Cornell Medical Center New York, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

NCT04802590

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • Universite Libre de Bruxelles - Hopital ERASME Brussels, Belgium
  • Hopital Jolimont Haine-Saint-Paul, Belgium
  • CHU de Liege Liège, Belgium
View all 45 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation

NCT04002297

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center (Bidmc) Boston, Massachusetts, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma

NCT02213926

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Niles, Illinois, United States
  • Research Site Peoria, Illinois, United States
View all 58 locations
View Trial Details

Related conditions